October 28, 2025 | Doctored Truths, Havas Lynx, Havas Village Manchester, Health Misinformation
“Doctored Truths” exposes the escalating crisis of health misinformation and disinformation, which has been ranked the world’s top short-term risk to the world, for the second year in a row. Havas Lynx calls upon the pharmaceutical industry to leverage its unique position and vast clinical data to combat this growing threat to patient health and public trust.

The Doctored Truths white paper highlights a critical erosion of trust in medical expertise, with proprietary Point.1 data revealing declining confidence in healthcare professionals (HCPs) across generations and only half of patients trusting non-government organisations like the World Health Organisation. As patients increasingly turn to digital platforms for health guidance, nearly one-third of social media health content now contains misinformation, leaving individuals vulnerable to conspiracy theories, viral fads, and unqualified advice.
The tangible impact of this misinformation overload is stark:
This crisis is affecting every therapy area, undermining public health, social cohesion, and even economic stability, particularly impacting vulnerable groups where scientific understanding is limited or access to care is constrained.
“The spread of health misinformation isn’t just a concern; it’s a profound threat to patient well-being and the very foundation of evidence-based medicine,” says Claire Knapp, Chief Executive Officer at Havas Lynx. “Our ‘Doctored Truths’ white paper not only illuminates the scale of this problem but also underscores the immense responsibility and opportunity for the pharmaceutical industry. Pharma could hold the antidote – with its deep scientific expertise and extensive reach, it is uniquely positioned to reclaim trust and safeguard health outcomes. It’s not just an ethical imperative, but a strategic necessity for the industry’s future.”
The expectations for the pharmaceutical sector to act are clear. Point.1 data shows that 71% of HCPs believe pharma has a responsibility to tackle misinformation, yet only 41% feel enough is currently being done. Havas Lynx asserts that by stepping up to this challenge, pharma can not only shape its future reputation but also reinforce the very foundations of evidence-based healthcare.
Read the full “Doctored Truths” report and learn how your organisation can contribute to this vital initiative here.
This content was provided by Havas Lynx
Company Details
Latest Content from Havas Lynx
Manchester based healthcare communications agency, Havas lynx, has launched its annual white paper campaign, which this year promotes the vital need to support the growing number of carers in our…
On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice…
On 16th April we met with a group of leading healthcare professionals and technology experts to learn more about how the new wave of cancer treatments are affecting everyday practice…
On 8th March 2018, we held our oncology caregivers focus group to discuss the role of a cancer caregiver in today’s care continuum, the challenges they face and potential solutions…
On 8th March 2018, we held our oncology caregivers focus group to discuss the role of a cancer caregiver in today’s care continuum, the challenges they face and potential solutions…
On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. In…
On 22nd February we held our patient experience focus group, which brought together patients, doctors and industry advocates to discuss the changing landscape and challenges facing cancer care today. “We…
We bring together the experts. The patients. The scientists. The technologists. The creatives. We unite powerful insights to make science mean something real. We are stronger together. We are Switched…
Matching unprecedented clinical advances in immuno-oncology with transformative communication
The caregivers’ story
